SG

Singapore

4110 clinical trials

Find Trials

Clinical Trials (4110)

Showing 20 of 4,110 trialsScroll for more

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

Recruiting
NCT06270459Not Applicable1 site

Telerehabilitation Robotics for Upper Limb Rehabilitation After STroke

Completed
NCT06430801Phase 33 sites

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Recruiting
NCT07491445Phase 32 sites

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Recruiting

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Active Not Recruiting
NCT06788990Phase 22 sites

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Recruiting
NCT03486873Phase 32 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT06780111Phase 11 site

Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)

Recruiting

User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems

Enrolling By Invitation
NCT07856030Not Applicable2 sites

Enhancing Patient Wellbeing Through Integration of Social Prescribing, Transitional Care, and Place-based Care in Community Hospitals Settings

Not Yet Recruiting
NCT05319730Phase 11 site

A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)

Recruiting
NCT06623422Phase 32 sites

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Recruiting
NCT04585750Phase 12 sites

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Recruiting
NCT02445222Phase 32 sites

CAR-T Long Term Follow Up (LTFU) Study

Recruiting
NCT07745816Not Applicable2 sites

Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere'

Not Yet Recruiting
NCT06956235Phase 22 sites

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

Active Not Recruiting

Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting
NCT07297745Not Applicable4 sites

Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA)

Recruiting

Targeting Osteosarcopaenia and Multimorbidity for Frailty Prevention

Recruiting
NCT06997497Phase 31 site

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Recruiting